相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Focusing on Core Patient-Reported Outcomes in Cancer Clinical Trials: Symptomatic Adverse Events, Physical Function, and Disease-Related Symptoms
Paul G. Kluetz et al.
CLINICAL CANCER RESEARCH (2016)
Quality of life and resilience related to chemotherapy-induced peripheral neuropathy in patients post treatment with platinums and taxanes
Mary Egan et al.
JOURNAL OF RESEARCH IN NURSING (2015)
Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity: two sides of the same coin
P. Alberti et al.
ANNALS OF ONCOLOGY (2014)
Chemotherapy-induced neuropathy: A comprehensive survey
N. C. Miltenburg et al.
CANCER TREATMENT REVIEWS (2014)
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
Dawn L. Hershman et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Phase III Randomized, Placebo-Controlled, Double-Blind Study of Intravenous Calcium and Magnesium to Prevent Oxaliplatin-Induced Sensory Neurotoxicity (N08CB/Alliance)
Charles L. Loprinzi et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Chemotherapy-induced peripheral neuropathy and its association with quality of life: a systematic review
Floortje Mols et al.
SUPPORTIVE CARE IN CANCER (2014)
The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings
G. Cavaletti et al.
ANNALS OF ONCOLOGY (2013)
Chemotherapy-Induced Neuropathy and Its Association With Quality of Life Among 2-to 11-Year Colorectal Cancer Survivors: Results From the Population-Based PROFILES Registry
Floortje Mols et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Assessing patient-reported peripheral neuropathy: the reliability and validity of the European Organization for Research and Treatment of Cancer QLQ-CIPN20 Questionnaire
Ellen M. Lavoie Smith et al.
QUALITY OF LIFE RESEARCH (2013)
Peripheral neuropathies from chemotherapeutics and targeted agents: diagnosis, treatment, and prevention
Wolfgang Grisold et al.
NEURO-ONCOLOGY (2012)
Assessing the impact of chemotherapy-induced peripheral neurotoxicity on the quality of life of cancer patients The introduction of a new measure
C. M. L. Driessen et al.
SUPPORTIVE CARE IN CANCER (2012)
The relationship between numbness, tingling, and shooting/burning pain in patients with chemotherapy-induced peripheral neuropathy (CIPN) as measured by the EORTC QLQ-CIPN20 instrument, N06CA
Sherry L. Wolf et al.
SUPPORTIVE CARE IN CANCER (2012)
Chemotherapy-Induced Peripheral Neurotoxicity assessment: A critical revision of the currently available tools
Guido Cavaletti et al.
EUROPEAN JOURNAL OF CANCER (2010)
Effects of a computer-supported interactive tailored patient assessment tool on patient care, symptom distress, and patients' need for symptom management support: a randomized clinical trial
Cornelia M. Ruland et al.
JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION (2010)
Bifactor Models and Rotations: Exploring the Extent to Which Multidimensional Data Yield Univocal Scale Scores
Steven P. Reise et al.
JOURNAL OF PERSONALITY ASSESSMENT (2010)
Model specification in oral health-related quality of life research
Jacobien M. Kieffer et al.
EUROPEAN JOURNAL OF ORAL SCIENCES (2009)
Feasibility and validity of the Patient Neurotoxicity Questionnaire during taxane chemotherapy in a phase III randomized trial in patients with breast cancer: N-SAS BC 02
Kojiro Shimozuma et al.
SUPPORTIVE CARE IN CANCER (2009)
Use of health-related quality-of-life assessments in daily clinical oncology nursing practice - A community hospital-based intervention study
Doranne L. Hilarius et al.
CANCER (2008)
Neurotoxicity from oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: NSABP C-07
Stephanie R. Land et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
The role of the bifactor model in resolving dimensionality issues in health outcomes measures
Steven P. Reise et al.
QUALITY OF LIFE RESEARCH (2007)
Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events: results of a questionnaire-based study
Ethan Basch et al.
LANCET ONCOLOGY (2006)
Diagnosis, management, and evaluation of chemotherapy-induced peripheral neuropathy
FH Hausheer et al.
SEMINARS IN ONCOLOGY (2006)
The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: The QLQ-CIPN20
TJ Postma et al.
EUROPEAN JOURNAL OF CANCER (2005)
Oxaliplatin-associated neuropathy: A review
RJ Cersosimo
ANNALS OF PHARMACOTHERAPY (2005)
Measuring quality of life in routine oncology practice improves communication and patient well-being: A randomized controlled trial
G Velikova et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
An empirical evaluation of alternative methods of estimation for confirmatory factor analysis with ordinal data
DB Flora et al.
PSYCHOLOGICAL METHODS (2004)
Grading of chemotherapy-induced peripheral neurotoxicity using the Total Neuropathy Scale
G Cavaletti et al.
NEUROLOGY (2003)
Measuring the side effects of taxane therapy in oncology - The functional assessment of cancer therapy-taxane (FACT-taxane)
D Cella et al.
CANCER (2003)
CTCAE v3.0: Development of a comprehensive grading system for the adverse effects of cancer treatment
A Trotti et al.
SEMINARS IN RADIATION ONCOLOGY (2003)
Common toxicity criteria: Version 2.0. an improved reference for grading the acute effects of cancer treatment: Impact on radiotherapy
A Trotti et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2000)
分享论文
